Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big ...

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

CEO resigns as Eli Lilly (LLY) dominates the weight loss drug market and compounders threaten the company's financial outlook ...

The discontinuation rate due to side effects was 6.1% for Zepbound and 8% for ... saying it would align US drug prices with ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

Traders should observe LLY’s price action for signals that may influence short-term crypto volatility ... and regulatory scrutiny surrounding weight-loss drugs, a key growth area for Eli Lilly.

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...

Novo Nordisk has replaced CEO Lars Fruergaard Jorgensen amid competitive pressures in the obesity drug market. His exit comes ...

Novo Nordisk CEO Lars Fruergaard Jorgensen will step down amidst growing concerns about the company's competitive position in ...

Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...

The discontinuation rate due to side effects was 6.1% for Zepbound and 8% for ... saying it would align US drug prices with the lowest-paying country. Eli Lilly’s stock has declined 5.6% so far in ...